Meeting
2018 Gastrointestinal Cancers Symposium
Tumor-normal sequencing to reveal frequency of false positive error rates with tumor-only sequencing in GI cancers and with RNA sequencing as a new standard of precision molecular profiling.
Authors
Chad Garner
NantOmics. LLC, Culver City, CA
Chad Garner , Sandip Reddy , John Z Sanborn , Stephen Charles Benz , Patrick Soon-Shiong , Shahrooz Rabizadeh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 224)
DOI
10.1200/JCO.2018.36.4_suppl.224
Abstract #
224
Poster Bd #
A21
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Evaluation of etiologic genetic polymorphisms by whole exome sequencing (WES) in the Mayo Clinic AML epidemiology cohort (MCAEC).
First Author: Zaid Abdel Rahman
Poster
2016 ASCO Annual Meeting
Molecular profiling of renal medullary carcinoma to reveal frequent alterations in chromatin remodeling genes and to identify EZH2 as a relevant therapeutic target.
First Author: Jianjun Gao
Poster
2016 Genitourinary Cancers Symposium
Molecular profiling of renal medullary carcinoma to reveal frequent alterations in chromatin remodeling genes and to identify EZH2 as a relevant therapeutic target.
First Author: Jianjun Gao
Poster
2023 ASCO Annual Meeting
Characterization of MCL-1 in patients with colorectal cancer (CRC): Expression, molecular profiles, and outcomes.
First Author: Pooja Mittal